Thymidylate Synthase Pharmacogenetics in Colorectal Cancer

This publication has 22 references indexed in Scilit:

• A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil
  British Journal of Cancer, 2001
• Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy
  The Pharmacogenomics Journal, 2001
• Ethnic Variation in the Thymidylate Synthase Enhancer Region Polymorphism among Caucasian and Asian Populations
  Genomics, 1999
• Identification of in vivo target RNA sequences bound by thymidylate synthase
  Nucleic Acids Research, 1996
• Effect of Hammerhead Ribozyme against Human Thymidylate Synthase on the Cytotoxicity of Thymidylate Synthase Inhibitors
  Japanese Journal of Cancer Research, 1995
• Functional Analysis and DNA Polymorphism of the Tandemly Repeated Sequences in the 5'-terminal Regulatory Region of the Human Gene for Thymidylate Synthase.
  Cell Structure and Function, 1995
• Posttranscriptional regulation of thymidylate synthase gene expression
  Journal of Cellular Biochemistry, 1994
• Identification of an RNA binding site for human thymidylate synthase.
  Proceedings of the National Academy of Sciences, 1993
• Regulatory sequences clustered at the 5? end of the first intron of the human thymidylate synthase gene function in cooperation with the promoter region
  Somatic Cell and Molecular Genetics, 1992
• Role in translation of a triple tandemly repeated sequence in the 5′-untranslated region of human thymidylate synthase mRNA
  Nucleic Acids Research, 1987